Characterization of the Rolipram-Sensitive, Cyclic AMP-Specific Phosphodiesterases: Identification and Differential Expression of Immunologically Distinct Forms in the Rat Brain-Reference-Cited by-同舟云学术

Characterization of the Rolipram-Sensitive, Cyclic AMP-Specific Phosphodiesterases: Identification and Differential Expression of Immunologically Distinct Forms in the Rat Brain

Published:1998-01-01 Issue:1 Volume:53 Page:23-32
ISSN:0026-895X
Container-title:Molecular Pharmacology
language:en
Short-container-title:Mol Pharmacol

Author:

Iona Saveria,Cuomo Margherita,Bushnik Tamara,Naro Fabio,Sette Claudio,Hess Martin,Shelton Earl R.,Conti Marco

Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Subject

Pharmacology,Molecular Medicine

Reference38 articles.

1. Characterization of Several Clonal Lines of Cultured Ley dig Tumor Cells: Gonadotropin Receptors and Steroidogenic Responses*

2. Multiple cyclic nucleotide phosphodiesterases.;Beavo;Mol Pharmacol,1994

3. A family of human phosphodiesterases homologous to the dunce learning and memory gene product of Drosophila melanogaster are potential targets for antidepressant drugs.;Bolger;Mol Cell Biol,1993

4. Differential CNS expression of alternative mRNA isoforms of the mammalian genes encoding cAMP-specific phosphodiesterases

5. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

Cited by 104 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The impact of phosphodiesterase inhibition on neurobehavioral outcomes in preclinical models of traumatic and non-traumatic spinal cord injury: a systematic review;Frontiers in Medicine;2023-08-22

2. An Overview of PDE4 Inhibitors in Clinical Trials: 2010 to Early 2022;Molecules;2022-08-04

3. Selective Inhibition of PDE4B Reduces Binge Drinking in Two C57BL/6 Substrains;International Journal of Molecular Sciences;2021-05-21

4. Principal component analysis of routine blood test results with Parkinson's disease: A case-control study;Experimental Gerontology;2021-02

5. A Novel PDE4D Inhibitor BPN14770 Reverses Scopolamine-Induced Cognitive Deficits via cAMP/SIRT1/Akt/Bcl-2 Pathway;Frontiers in Cell and Developmental Biology;2020-12-10